HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is gastric tube reconstruction the optimal surgical procedure for Siewert type II esophagogastric junction carcinoma?

AbstractBACKGROUND/AIM:
To evaluate the potential risk of gastric tube reconstruction for Siewert type II esophagogastric junction carcinoma.
PATIENTS AND METHODS:
We retrospectively analyzed clinicopathological and survival data of 41 patients who had undergone total gastrectomy for Siewert type II carcinoma, focusing on lymph node metastasis around the middle to lower greater curvature or parapyloric area.
RESULTS:
Histological examination showed involvement of at least one lymph node in six patients (14%). Multivariate Cox proportional hazard regression analysis of seven clinicopathological variables showed that lymph node metastasis around the middle to lower greater curvature, or parapyloric area was the only significant independent unfavorable factor (odds ratio=6.62; 95% confidence interval=1.27-41.1; p=0.03) for survival. We identified no significant predictors of lymph node metastasis in analyzed patients.
CONCLUSION:
From an oncological point of view, we do not recommend routine gastric tube reconstruction for Siewert type II carcinoma.
AuthorsMinoru Fukuchi, Erito Mochiki, Okihide Suzuki, Toru Ishiguro, Jun Sobajima, Kana Saito, Hiroshi Naitoh, Youichi Kumagai, Hiroyuki Baba, Keiichiro Ishibashi, Hideyuki Ishida
JournalAnticancer research (Anticancer Res) Vol. 34 Issue 2 Pg. 915-9 (Feb 2014) ISSN: 1791-7530 [Electronic] Greece
PMID24511032 (Publication Type: Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Esophagogastric Junction (pathology, surgery)
  • Female
  • Gastrectomy
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Plastic Surgery Procedures
  • Retrospective Studies
  • Stomach Neoplasms (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: